Mesanenin taşlı yüzük hücreli ve müsinöz adenokarsinomu: Olgu sunumu

Year 2013, Volume: 8 Issue: 3, 62 - 65, 01.08.2013

Fatih Akdemir¹ Kemal Ener¹ Mustafa Aldemir¹ Emrah Okulu¹ Evren Işık¹ Muhammet Fuat Özcan¹ Aylin Kılıç Yazgan²

Abstract

Adenokarsinomlar, mesane tümörlerinin çok az bir kısmını oluşturup, genellikle metastatik orijinlidirler. Daha nadir rastlanan primer mesane adenokarsinomlarının oluşum tion of primary bladder adenocarcinomas has mekanizması ise henüz netlik kazanmamıştır. not been purified yet. These tumours have poor Bu tümörler kötü prognozlu olup, tanı anında çoğunlukla kasa invaze olmuş durumdadırlar. Radyoterapinin etkili olmadığı bu tümörlerde, kemoterapi deneyimi ise azdır. Erken evrede tespit edilen primer mesane adenokarsinomlarında, en iyi tedavi seçeneği halen radikal sistektomidir

Keywords

Mesane kanseri , müsinöz adenokarsinom , taşlı yüzük hücreli adenokarsinom

Signet ring cell and musinous adenocarcinoma of the bladder: Case report

Abstract

Adenocarcinomas consist of a small part of bladder tumours and, they are usually metastatic originated. The mechanism of formation of primary bladder adenocarcinomas has not been purified yet. These tumours have poor prognosis, and they are usually muscle invasive during diagnosis. Radiotherapy has no efficiency at this tumour, on the other hand the experience for chemotherapy is inadequate. Currently, the best treatment choice for early diagnosed primary blad

Keywords

Bladder cancer , musinous adenocarcinoma , signet ring cell adenocarcinoma

References

• Thomas DG, Ward AM, Williams JL:A study of 52 cases of adenocarcinoma of the bladder. Br J Urol 1971;43:4-15.
• Abenoza P, Manivel C, Fraley EE. Primary adenocarcinoma of the urinary bladder. Clinicopathologic study of 16 cases. Urology 1987;29:9-14.
• Peterson RO. Urologic Pathology, Philadelphia, J.b. Lippin- cott company 1986, pp. 288-290, 354-360, 382-384.
• Zaghloul MS, Nouh A, Nazmy M, Ramzy S, Zaghloul AS, Sedira MA, Khalil E. Long-term results of primary adeno- carcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 2006;24:13-20.
• Fiter L, Gimeno F, Martin L, et al. Signet-ring cell adenocar- cinoma of bladder. Urology 1993;41:30-3.
• Bowlby LS, Smith ML. Signet ring cell carcinoma of the uri- nary bladder. Primary presentation as a Krukenberg tumor. Gynecol Oncol 1986;25:376-81.
• Choi H, Lamb S, Pintar K, et al. Primary signet ring cell carcinoma of the urinary bladder. Cancer 1984;53:1985-90.
• Austin GE, Safford J. Signet ring cell carcinomaof the blad- der. Urology 1978;12:458-60.
• Grignon DJ, Ro JY, Ayala AG, et al. Primary signet ring cell carcinoma of bladder. Am J Clin Pathol 1991;95:13-20.
• Dow JA, Young JD Jr. Mesonephric adenocarcinoma of the bladder. J Urol 1968;100:466-9.
• Nielsen K, Nielsen KK. Adenocarcinoma in exstrophy of the bladder--the last case in Scandinavia? A case report and re- view of literature. J Urol 1983;130:1180-2.
• Blute ML, Engen DE, Travis WD, et al. Primary signet ring adenocarcinoma of bladder. J Urol 1989;141:17-21.
• Kıroğlu Y, Yerlikaya İ, Erkuş M. Mesanenin Taşlı Yüzük Hücreli Karsinomu, Türk Patoloji Dergisi 1992;8-1:79-80.
• Schoenberg M. Management of Invasive and Metastatic Bladder Cancer. Philadelphia: W.B. Saunders; 2002. p. 2803- 2817.